Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > IMRX Immuneering > Detailed Quotes

IMRX Immuneering

Watchlist
6.4900.0000.00%
Trading Session 12/01 12:36 ET
High
0.000
Open
6.410
Turnover
4.42K
Low
0.000
Pre Close
6.490
Volume
700.00
Market Cap
171.37M
P/E(TTM)
Loss
52wk High
23.970
Shares
26.40M
P/E(Static)
Loss
52wk Low
3.740
Float Cap
89.73M
Bid/Ask %
-33.33%
Historical High
33.990
Shs Float
13.83M
Volume Ratio
0.05
Historical Low
3.740
Dividend TTM
--
Div Yield TTM
--
P/B
1.41
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.01%
Amplitude
0.00%
Avg Price
6.312
Lot Size
1
Float Cap
89.73M
Bid/Ask %
-33.33%
Historical High
33.990
Shs Float
13.83M
Volume Ratio
0.05
Historical Low
3.740
Dividend TTM
--
P/B
1.41
Dividend LFY
--
Turnover Ratio
0.01%
Amplitude
0.00%
Avg Price
6.312
Lot Size
1
Price Forecast

No Data

News

Comment

Sign in to post a comment

No comment yet

Company Overview More
Immuneering Corp. engages in the development of new medicines which are unlikely to be found by traditional drug discovery methods. Its pipeline of drug candidates focuses on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis. The company was founded by Robert J. Carpenter and Benjamin J. Zeskind in 2008 and is headquartered in Cambridge, MA.
CEO: Dr. Benjamin J. Zeskind, PhD
Market: NASDAQ
Listing Date: 07/30/2021
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist